Brief Interventions for Harmful Alcohol Use in Opioid-dependent Patients on Maintenance Treatment With Buprenorphine: A Prospective Study From India

被引:11
|
作者
Varshney, Mohit
Ambekar, Atul [1 ,2 ]
Lal, Rakesh
Yadav, Deepak
Rao, Ravindra
Mishra, Ashwani
机构
[1] All India Inst Med Sci, Dept Psychiat, New Delhi 110029, India
[2] All India Inst Med Sci, Natl Drug Dependence Treatment Ctr, New Delhi 110029, India
来源
ADDICTIVE DISORDERS & THEIR TREATMENT | 2016年 / 15卷 / 03期
关键词
Brief Intervention; harmful alcohol use; buprenorphine; opioid substitution therapy;
D O I
10.1097/ADT.0000000000000076
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Harmful/hazardous alcohol use is common among individuals receiving opioid substitution therapy (OST). The World Health Organisation (WHO) recommends use of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)-linked Brief Interventions (BI) for managing harmful alcohol use. However, the feasibility and effectiveness of BI in addressing harmful alcohol use among buprenorphine-maintained OST recipients has not been studied, which was the objective of the present study. Methods: Using a prospective study design, OST recipients were screened with WHO-ASSIST, and those in the harmful/hazardous use category were administered BI sessions. The feasibility of BI was assessed using BI process rating form. Alcohol-related quantitative variables were assessed with WHO-ASSIST and Rutgers Alcohol Problem Index at baseline and 12 weeks post-BI, and compared for measuring BI effectiveness. Results: Thirty-six (of 138 OST recipients screened) had ASSIST scores in the harmful hazardous category at baseline, and underwent 2 BI sessions at 1 to 2 weeks apart. Of these, 35 patients completed all BI sessions, and baseline and end-line assessments. The average time taken for 1 BI session was 26.43 minutes; 54% reported a "significant influence'' of BI on alcohol consumption; 88% reported that they attempted to cut down alcohol use; 14% completely stopped drinking; and another 14% reported significant reduction in alcohol consumption. ASSIST and Rutgers Alcohol Problem Index scores were significantly reduced at end-line assessment. Conclusion: BI is a feasible and effective intervention to address harmful/hazardous drinking among buprenorphine-maintained opioid-dependent patients.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 50 条
  • [31] Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
    Roux, Perrine
    Castro, Daniela Rojas
    Ndiaye, Khadim
    Madrid, Laelia Briand
    Laporte, Virginie
    Mora, Marion
    Maradan, Gwenaelle
    Morel, Stephane
    Spire, Bruno
    Carrieri, Patrizia
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2017, 12
  • [32] Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome
    Jones, HE
    Johnson, RE
    Jasinski, DR
    O'Grady, KE
    Chisholm, CA
    Choo, RE
    Crocetti, M
    Dudas, R
    Harrow, C
    Huestis, MA
    Jansson, LM
    Lantz, M
    Lester, BM
    Milio, L
    DRUG AND ALCOHOL DEPENDENCE, 2005, 79 (01) : 1 - 10
  • [33] Office-Based Buprenorphine Treatment Identifying Factors That Promote Retention in Opioid-Dependent Patients
    Noe, Shelly R.
    Keller, Teresa
    JOURNAL OF ADDICTIONS NURSING, 2020, 31 (01) : 23 - 29
  • [34] Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients
    Mattick, RP
    Ali, R
    White, JM
    O'Brien, S
    Wolk, S
    Danz, C
    ADDICTION, 2003, 98 (04) : 441 - 452
  • [35] A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi'an
    Wei, Xiaoli
    Wang, Lirong
    Wang, Xueliang
    Li, Jinsong
    Li, Hengxin
    Jia, Wei
    JOURNAL OF ADDICTION MEDICINE, 2013, 7 (05) : 342 - 348
  • [36] Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy
    Gastberger, Salome
    Baumgartner, Markus R.
    Soyka, Michael
    Quednow, Boris B.
    Hulka, Lea M.
    Herdener, Marcus
    Seifritz, Erich
    Mutschler, Jochen
    EUROPEAN ADDICTION RESEARCH, 2019, 25 (04) : 207 - 212
  • [37] EFFICACY OF BUPRENORPHINE/NALOXONE COMBINATION IN REDUCING INTRAVENOUS MISUSE IN OPIOID-DEPENDENT PATIENTS (RIME STUDY)
    Touzeau, D.
    ALCOHOL AND ALCOHOLISM, 2014, 49
  • [38] Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone
    Fiellin, David A.
    Weiss, Linda
    Botsko, Michael
    Egan, James E.
    Altice, Frederick L.
    Bazerman, Lauri B.
    Chaudhry, Amina
    Cunningham, Chinazo O.
    Gourevitch, Marc N.
    Lum, Paula J.
    Sullivan, Lynn E.
    Schottenfeld, Richard S.
    O'Connor, Patrick G.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 : S33 - S38
  • [39] Buprenorphine-Naloxone Versus Methadone Maintenance Therapy: A Randomised Double-Blind Trial With Opioid-Dependent Patients
    Kamien, Jonathan B.
    Branstetter, Steven A.
    Amass, Leslie
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2008, 10 (04) : 5 - 18
  • [40] Inpatient initiation of buprenorphine maintenance vs. detoxification: Can retention of opioid-dependent patients in outpatient counseling be improved?
    Caldiero, RM
    Parran, TV
    Adelman, CL
    Piche, B
    AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (01): : 1 - 7